HOWARU library - Rhamnosus

Cross M L, Mortensen R R, Kudsk J, Gill H S. Dietary intake of Lactobacillus rhamnosus HN001 enhances production of both Th1 and Th2 cytokines in antigen-primed mice. Med Microbiol Immunol 2002; (191): 49-53.

Gill H, Rutherfurd K J, Cross M L. Dietary probiotic supplementation enhances natural killer cell activity in the elderly: an investigation of age-related imunological changes. J Clin Immunol 2001a; (21): 264-271.

Gill H S. Stimulation of the immune system by lactic cultures. Int Dairy J 1998; (8): 535-544.

Gill H S, Cross M L, Rutherfurd K J, Gopal P K. Dietary probiotic supplementation to enhance cellular immunity in the elderly. Br J Biomed Sci 2001b; (58): 94-96.

Gill H S, Shu Q, Lin H, Rutherfurd K J, Cross M L. Protection against translocating Salmonella typhimurium infection in mice by feeding the immuno-enhancing probiotic Lactobacillus rhamnosus strain HN001. Med Microbiol Immunol 2001c; (190): 97-104.

Gill H, Rutherfurd K J, Cross M L. Dietary probiotic supplementation enhances natural killer cell activity in the elderly: an investigation of age-related imunological changes. J Clin Immunol 2001a; (21): 264-271.

Gill H S, Darragh A J, Cross M L. Optimizing immunity and gut function in the elderly. J Nutr Health Aging 2001c; (5): 80-91.

Gill H S, Rutherfurd K J, Prasad J, Gopal P K. Enhancement of natural and acquired immunity by Lactobacillus rhamnosus (HN001), Lactobacillus acidophilus (HN017) and Bifidobacterium lactis (HN019). Br J Nutr 2000; (83): 167-176.

Gopal P, Dekker J, Prasad Y, Pillidge C J, Delabre M-L, Collett M. Development and commercialisation of Fonterra's probiotic strains. Aust J Dairy Technol 2005; (60): 173-182.

Gopal P K, Prasad J, Smart J, Gill H S. In vitro adherence properties of Lactoacillus rhamnosus DR20 and Bifidobacterium lactis DR10 strains and their antagonistic activity against an enterotoxigenic Escherichia coli. Int J Food Microbiol 2001a; (67): 207-216.

Gopal P K, Sullivan P A, Smart J B. Utilisation of galacto-oligosaccharides as selective substrates for growth by lactic acid bacteria including Bifidobacterium lactis DR10 and Lactobacillus rhmanosus DR20. Int Dairy J 2001b; (11): 19-25.

Prasad J, Gill H, Smart J, Gopal P K. Selection and characterisation of Lactobacillus and Bifidobacterium strains for use as probiotics. Int Dairy J 1998; (8): 993-1002.

Sheih Y-H, Chiang B-L, Wang L-H, Liao C-K, Gill H S. Systemic immunity-enhancing effects in healthy subjects following dietary consumption of the lactic acid bacterium Lactobacillus rhamnosus HN001. J Am Coll Nutr 2001; (20): 149-156.

Shu Q, Gill H S. Immune protection mediated by the probiotic Lactobacillus rhamnosus HN001 (DR20(tm)) against Escherichia coli 0157:H7 infection in mice. FEMS Immunol Med Microbiol 2002; (34): 59-64.

Shu Q, Zhou J S, Rutherfurd K J, Britles M J, Prasad J, Gopal P K, Gill H. Probiotic lactic acid bacteria (Lactobacillus acidophilus HN017, Lactobacillus rhamnosus HN001 and Bifidobacterium lactis HN019) have no adverse effects on the health of mice. Int Dairy J 1999b; (9): 831-836.

Tannock G W, Munro K, Harmsen H J M, Welling G W, Smart J, Gopal P K. Analysis of the fecal microflora of human subjects consuming a probiotic product containing Lactobacillus rhamnosus DR20. Appl Environ Microbiol 2000; (66): 2578-2588.

Zhou J S, Gill H S. Immunostimulatory probiotic Lactobacillus rhamnosus HN001 and Bifidobacterium lactis HN019 do not induce pathological inflammation in mouse model of experimental autoimmune thyroiditis. Int J Food Microbiol 2005; (103): 97-104.

Zhou J S, Gopal P K, Gill H S. Potential probiotic lactic acid bacteria Lactobacillus rhamnosus (HN001), Lactobacillus acidophilus (HN017) and Bifidobacterium lactis (HN019) do not degrade gastric mucin in vitro. Int J Food Microbiol 2001; (63): 81-90.

Zhou J S, Pillidge C J, Gopal P K, Gill H S. Antibiotic susceptibility profiles of new probiotic Lactobacillus and Bifidobacterium strains. Int J Food Microbiol 2005a; (98): 211-217.

Zhou J S, Rutherfurd K J, Gill H S. Inability of probiotic bacterial strains Lactobacillus rhamnosus HN001 and Bifidobacterium lactis HN019 to induce human platelet aggregation in vitro. J Food Prot 2005b; (68): 2459-2464.

Zhou J S, Shu Q, Rutherfurd K J, Prasad J, Britles M J, Gopal P K, Gill H S. Safety assessment of potential probiotic lactic acid bacteria strains Lactobacillus rhamnosus HN001, Lb. acidophilus HN017, and Bifidobacterium lactis HN019 in BALB/c mice. Int J Food Microbiol 2000a; (56): 87-96.

Zhou J S, Shu Q, Rutherfurd K J, Prasad J, Gopal P K, Gill H. Acute oral toxicity and bacterial translocation studies on potentially probiotic strains of lactic acid bacteria. Food Chem Toxicol 2000b; (38): 153-161.